With TherapyMonitor, you can get comprehensive analyses derived from the latest longitudinal physician-supplied data on European oncology care. Collaborating with medical experts and pharmaceutical leaders, our European-based TriNetX Oncology team tailors report specifications for precise study objectives in oncological and rare-disease indications. Unearth complete, representative, and high-quality data, offering valuable insights into disease prevalence, treatment patterns, and market dynamics across the continent.

What’s Inside TherapyMonitor

TherapyMonitor’s projects are based on carefully collected and organized data pertaining to patients over time, focusing on specific medical conditions or indications. This data includes structured information, such as demographics, medical history, and treatment regimens, and unstructured data, like clinical notes or imaging results. Additionally, the data is thoroughly curated to ensure accuracy and relevance to the specific project objectives.

With TherapyMonitor, all patient data is rendered fully anonymous, ensuring strict compliance with the most stringent regulations governing software and processes. 

Precision Data Collection for Tailored Insights of Every Patient Journey

We collect thousands of variables per patient and treatment journey, from initial diagnoses to most recent encounters. Together with our clients and medical experts, we generate a fit-for-purpose questionnaire and database to match desired analyses.

• Comprehensive individual patient demographics and disease characteristics
• Highly granular diagnostics and cytogenetics data, therapy and drug-specific data including timestamps for all therapy events modifications
• Detailed information on outcomes, assessment method and progression and/or relapse definition according to clinical guidelines including caregiver definition. The outcomes are available for each separate treatment line
• Institutional characteristics and patient clinical pathway

Reflecting Real-World Patient Care in Europe

TherapyMonitor covers the EU5 and smaller European nations, providing a comprehensive view of cancer care across the continent. It encompasses a wide range of patient and disease data, treatment records, outcome assessments, and institutional information. Our data is of regulatory-grade quality, derived from representative samples of patients and healthcare institutions in each country included in our project scope of work.

including Germany, France, Spain, and United Kingdom

hematological diseases and solid tumors

Analysis precision: 95% CL / 05% CI

Stay Ahead with Quarterly Updates

TherapyMonitor provides regulatory-grade reports refreshed every 3 months, delivering up-to-date insights into patient data and outcomes. Leading healthcare innovation, our cutting-edge analyses shape critical decision-making processes.

TherapyMonitor analyses are regularly utilized for:

TherapyMonitor

Explore a comprehensive analysis unveiling current disease prevalence, treatment patterns, and indication-specific market dynamics based on longitudinal, patient-level data. TherapyMonitor is scalable regarding indication and region, allows for fit-for-purpose research focused on specific target populations, and is based on fully anonymized data.

Inside you’ll discover insights on:

• Baseline/Demographics
• Current Therapy Status
• Initial Diagnosis
• Induction Therapy (for each line of treatment)
• Stem Cell Transplantation Measures (for each line of treatment)
• CAR-T Therapy Measures (for each line of treatment)
• Supportive Therapy and Adverse Event Prophylaxis (for each line of treatment)
• Best Achieved Outcomes/Response Assessments (for each line of treatment)